Mereo Biopharma Group Plc(GB:0A9G)
$0.27-0.02 (-5.36%)
GB:0A9G
Mereo Biopharma Group Plc financials statements
$0.27
At close:-0.02 (-5.36%)
Mereo Biopharma Group Plc (0A9G) Income Statement
1 Followers
Mereo Biopharma Group Plc Income Statement
Last quarter (Q3 2026), Mereo Biopharma Group Plc's total revenue was $800.00K. In Q3, Mereo Biopharma Group Plc's net income was $-5.86M. See Mereo Biopharma Group Plc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 500.00K | $ 0.00 | $ 10.00M | $ 0.00 | $ 36.46M | |
| $ 367.00K | $ -1.09M | $ 7.43M | $ 1.15M | $ 18.56M | |
| $ 38.62M | $ 47.36M | $ 35.84M | $ 55.57M | $ 39.49M | |
| Depreciation and Amortization | $ 1.15M | $ 1.09M | $ 1.06M | $ 889.00K | $ 642.00K |
| $ -40.47M | $ 1.09M | $ -26.06M | $ -37.87M | $ 18.91M | |
| $ -38.26M | $ -47.38M | $ -28.42M | $ -54.43M | $ -20.94M | |
| $ -3.62M | $ 4.11M | $ -1.58M | $ 11.49M | $ 35.18M | |
| $ -41.88M | $ -43.25M | $ -30.00M | $ -42.94M | $ 14.24M | |
| $ -41.88M | $ -43.25M | $ -29.47M | $ -42.22M | $ 12.72M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.26 | $ -0.30 | $ -0.22 | $ -1.80 | $ 0.10 |
| Diluted EPS | $ -0.26 | $ -0.30 | $ -0.22 | $ -1.80 | $ -0.25 |
| Weighted Average Shares Outstanding | 159.42M | 29.58M | 131.89M | 22.80M | 105.56M |
| Weighted Average Shares Outstanding (Diluted) | 159.42M | 29.58M | 131.89M | 22.80M | 111.06M |
Currency in USD

